A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03769116 · COMPLETED
Trial details
- NCT number
- NCT03769116
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2020-12-08
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.